https://www.avient.com/resource-center?document_subtype=127&document_type=59&form_build_id=form-Ojq3VtEkRrXIsgZSyKvAgO_Z3JHuKtjJLR7xfOXoAI8&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=81&product_name=0&product_subfamily=0&page=2
Disposable Medical Tray
Gravi-Tech™ material delivered customized density and supported electroplating to give the look and feel of metal
Medical Device Housing
https://www.avient.com/news/invisio-color-inspiration-2019-explores-color-strategies-rooted-art-and-design-evolution
When it comes to color’s role in this evolution, it’s clear that trends based on deep-rooted societal changes have greater authenticity and staying power than more ephemeral fads.
About PolyOne
Featured Articles
https://www.avient.com/sites/default/files/resources/11.30.18%2520Investor%2520Presentation%2520V1.pdf
They are based on management’s expectations that involve a
number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by
the forward-looking statements.
T H E N E W P O L Y O N E : A S P E C I A L T Y G R O W T H C O M P A N Y
Growing leadership position in attractive markets
Innovation, technology and service are differentiators
Capital management is a strength: Record-setting cash generation
to continue for years
Expand ROIC while increasing invested capital
Proven acquisition strategy with robust pipeline
Commercial investments are fueling momentum and generating
organic growth
SERVICE:
T H E T I M E L E S S
D I F F E R E N T I A T O R
PolyOne Corporation 29
T A L E N T D E V E L O P M E N T
PolyOne Corporation 30
Leadership Program Participants
2012
2013
2015
47
86
2016
125
169
315
Campus Hires
2008
2011
2017
25
47
PolyOne LSS Blackbelts
2008
2011
67
220
147
2018 141
A U N I Q U E C U S T O M E R E X P E R I E N C E
Industrial
Design
IQ DESIGN LABS
PolyOne Corporation 31
Material
& Color
Expertise
Manufacturing
Expertise
3
14
Industrial designers
$0
$7M
$4M
$40M
Opportunity funnel New business revenue
LSS CUSTOMER FIRST
PolyOne Corporation 32
Customer Projects
Enables sales growth by building more intimate
customer relationships, giving us insight to customers’
needs, with a service that is not easily replicated
2 85
3 D P R I N T I N G
B R I N G I N G N E W I D E A S T O L I F E
PolyOne Corporation 33
Enables validation of fit and function
Shortens design cycle and time to market
Avoids tooling rework
Drives innovation
Delivers substantial customer value
PolyOne Corporation 34
From concept to production
99.9%
Reduction in
turnaround time
Traditional Timeline
up to 24 weeks
PolyOne ColorMatrix
Select™
6 hours
Innovative system for processors and OEMs to develop colors in real time
Complete system that provides customers with the freedom to match,
prototype and produce color entirely within their own facility
C O L O R M A T R I X S E L E C T ™
“Being able to create color and produce parts in 1 day is unheard of in this industry”
-CEO, Industry Leader
I N N O V A T I N G W I T H P O L Y O N E
PolyOne Corporation 35
SEGMENT HIGHLIGHTS
C O L O R , A D D I T I V E S & I N K S
PolyOne Corporation 36
Solid
Colorants
Performance
Additives
Screen
Printing Inks
Liquid
Colorants
27%
14%
Textiles
Building &
10%
10%Transportation
Electrical &
Operating Income & MarginRevenue by Region
C O L O R , A D D I T I V E S & I N K S
2 0 1 7 R E V E N U E | $ 8 9 3 M I L L I O N
$4
$25
$104
$139
0.9%
5.5%
12.2%
15.5%
16.0%
18.0%
100
110
120
130
140
150
PolyOne Corporation 37
32%
46%
1%
Mexico
Brazil
S P E C I A L T Y E N G I N E E R E D M A T E R I A L S
PolyOne Corporation 38
Engineered
Formulations
Advanced
Thermoplastic
Elastomers
20%
19%
13%
Building &
Electrical &
S P E C I A L T Y E N G I N E E R E D M A T E R I A L S
Revenue by Region Operating Income & Margin
2 0 1 7 R E V E N U E | $ 6 2 4 M I L L I O N
PolyOne Corporation 39
$21
$57
$76
0.1%
5.1%
9.3%
28%
48%
22%
12.1%
P E R F O R M A N C E P R O D U C T S & S O L U T I O N S
PolyOne Corporation 40
Specialty Vinyl
Solutions
Healthcare
Formulations
Smart Device
Materials
Flame Retardant
Polymers
Building &
30%
Electrical &
1%
Asia
77%
Mexico
P E R F O R M A N C E P R O D U C T S & S O L U T I O N S
Operating Income & MarginRevenue by Region
2 0 1 7 R E V E N U E | $ 7 2 1 M I L L I O N
$40
$24
$56
$77
4.6%
3.6%
7.2%
10.7%
16.0%
10
100
PolyOne Corporation 41
$886 $668 $773 $721Sales
D I S T R I B U T I O N
E N D M A R K E T S & S U P P L I E R S
PolyOne Corporation 42
23%
22%
Electrical &
Building &
$20
$25
$63
$73
2.9%
5.9%
6.3%
1.0%
3.0%
5.0%
7.0%
15
25
35
45
55
65
75
Operating Income & Margin2017 Revenue | $1.2 Billion
http://www.polyone.com/Pages/VariationRoot.aspx
T A R G E T E N D M A R K E T S &
A P P L I C A T I O N E X A M P L E S
PolyOne Corporation 43
Thermally Conductive
Chemical Resistant
Polymer Colorants
Elastomeric Grips and
Handles
Structural Composites
Antimicrobial Technologies
Anti-Counterfeiting
Target End Markets… Healthcare
Catheter Technologies
Under-hood Components
Target End Markets… Automotive
Interior Structural
Sound & Vibration
Management
Roof Systems
Air Management
Electronics and Cameras
Lighting
Exterior / Interior Trim
Braces & Brackets
Fasteners
Seals & Flaps
Target End Markets… Consumer
Thermally Conductive
Polymer Colorants
Elastomeric Grips and
Handles
Structural Composite
Oxygen Scavenger
Laser Marking Additives
Antistatic Technologies
UV Light Barrier Technologies
Cap & Closure Colorants
Process Optimization
Antioxidant Technologies
Density Modified
Target End Markets… Packaging
Impart weight, sound and
metallic finish to caps and
closures for cosmetics and
spirits applications
Elevate quality and
prestige perceptions
among high-end
consumers
Eliminate time and cost
associated with secondary
operations and assembly
Luxury Packaging
GravitechTM Density Modified Polymers
Eliminate costs by
increasing pigment density
Enhance color
performance without
altering form and
formulation
Increase design
capabilities by reducing
weight and layer thickness
Optimize Color Usage
OnColorTM Super Concentrates
Inhibit microbial growth on
polymer surfaces
Enhance value or products
and devices
Highly versatile
concentrate with the
ability to be incorporated
into a wide variety of
products
Combat Bacteria Formation
WithStandTM Antimicrobial Technology
Durable, long-lasting products stand
up to the most aggressive
disinfectants
Minimize environmental stress
cracking and discoloration
One of the broadest medically
approved polymer and colorant
portfolios
Medical Device Housings
Chemically Resistant Engineered Polymers
Color & Design Services
Greater control of color
development and supply chain
Work across entire design
process from concept to
commercialization
Inspire creativity in the use of
polymer materials, colors, and
effects
Innovative brand differentiation
Faster development timelines
Outdoor Applications
Leading provider of high
performance specialty materials
for the recreational and sports &
leisure industry
Well positioned across all
segments to address market needs
Metal to Polymer Conversion
Lightweighting
Thermal Management
Impact Performance
ColorMatrix Fiber Colorant
Solutions
Proprietary advanced liquid color
formulations and equipment
enable greater efficiency and
productivity
Eliminates aqueous dyeing and its
associated wastewater treatment
Solid Color Concentrates
Extrusion-spun fibers colored via
solid masterbatch
Fiber Colorants
High flame retardancy to
meet strict UL standards
Greater processing and
design flexibility
Specialized additives
provide long term color
stability
Diffusive lens materials
improve light dispersion
Smart Home Devices
ResilienceTM Vinyl Solutions
PolyOne investor presentation
Forward Looking Statements
USE OF �NON-GAAP�MEASURES
Vision
Safety First
PolyOne�2017 Revenue | $3.2 billion
Proof of Performance
Sustainable Path to Double-Digit EPS Growth
Investment in Commercial Resources driving growth
The Evolving Customer Relationship
Slide Number 11
New Resources Fueling the Future
Aligning with trends for Growth
Innovation
3 Horizons of Development
Innovation Pipeline
Innovation Spotlight: Composites
Composites Refresher
Strategic Investment History
COMPOSITES in Transportation
Invest-to-Grow M&A Strategy
Invest-to-Grow M&A Playbook
Invest-to-Grow Proof of performance
Invest-to-Grow Driving the future
Strong Pipeline�driven by fragmented Market
Returning cash to shareholders�Over $1 Billion since 2011
ROIC drives shareholder return
Why Invest In PolyOne?
Service:�The Timeless differentiator
Talent development
IQ DESIGN LABS
LSS CUSTOMER FIRST
3D Printing�Bringing New ideas to life
Slide Number 34
Innovating with PolyOne
COLOR, ADDITIVES & INKS
Color, Additives & Inks
Specialty Engineered Materials
Specialty Engineered Materials
Performance Products & Solutions
Performance Products & Solutions
DISTRIBUTION
Target end markets & �application examples
Slide Number 44
Slide Number 45
Slide Number 46
Slide Number 47
Slide Number 48
Slide Number 49
Slide Number 50
Slide Number 51
Slide Number 52
Slide Number 53
Slide Number 54
Slide Number 55
https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-dynaflex-medical-face-mask.pdf
EUROPEAN MEDICAL
DEVICE MANUFACTURER
F A C E M A S K V E N T I L A T I O N
V A L V E
• ISO 9001 and USP VI compliant
• Compatible with overmolding onto PP
• Translucent and highly colorable
• Soft touch
• Provided valuable regulatory support and
documentation, enabling faster internal trials and
material qualification for this customer
• Worked together with customer to select the best
material from a broad portfolio of medical TPE
grades
• Trusted as a polymer supplier for multiple
healthcare applications
Dynaflex™ G2711 Thermoplastic Elastomer
KEY REQUIREMENTS
WHY AVIENT?
AVIENT SOLUTION
BIOCOMPATIBILITY + SOFT TOUCH
LEARN MORE
© 2020, All Right Reserved
Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012
https://www.polyone.com/products/thermoplastic-elastomers/dynaflex-thermoplastic-elastomers
European medical device manufacturer
https://www.avient.com/knowledge-base/article/whats-difference-tpes-vs-silicones
On the other hand, bio-sourced tend to be more opaque, making them easily colorable, but they do have a different tint than prime raw materials.
In Handbook of Polymer Applications in Medicine and Medical Devices,¹ Laurence W.
¹http://store.elsevier.com/Handbook-of-Polymer-Applications-in-Medicine-and-Medical-Devices/isbn-9780323221696/
https://www.avient.com/knowledge-base/article/whats-difference-tpes-vs-silicones?ind[]=21537
On the other hand, bio-sourced tend to be more opaque, making them easily colorable, but they do have a different tint than prime raw materials.
In Handbook of Polymer Applications in Medicine and Medical Devices,¹ Laurence W.
¹http://store.elsevier.com/Handbook-of-Polymer-Applications-in-Medicine-and-Medical-Devices/isbn-9780323221696/
https://www.avient.com/industries/packaging/beverage-packaging/water
Catheter Materials & Medical Tubing
Medical Devices & Equipment
Medical Device Trays and Kits
https://www.avient.com/knowledge-base/article/minimize-fogging-food-packaging
Effective solutions exist to keep your packaging clear, and recent developments make it easier than ever to do so.
For greater benefit, anti-fogging additives can be combined with other functional features in films to increase the overall customer-friendliness of a complete package.
Learn more about your anti-fogging options by contacting an expert at Avient today!
https://www.avient.com/sites/default/files/2022-04/MEVOPUR LQ for Silicone Elastomers.pdf
Avient products have not been designed for nor are they promoted or intended for use in:
(a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under
US Pharmacopoeia (USP) or ISO standards; or
(b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or
(c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended.
Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for:
(1) exposure to human tissue or body fluids for 30 days or greater;
(2) “plastic” (cosmetic or reconstructive) surgery use;
(3) reproductive implants or any birth control device; or
(4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device, including the suitability of all raw materials and
components used for its manufacture, and with all applicable laws and regulations.
1.844.4AVIENT
www.avient.com
https://www.avient.com/news/polyone-announces-record-first-quarter-2014-results
Featured Articles
More
More